F11 Gene - Coagulation Factor XI

Genetic and Functional Insights into Factor XI Deficiency and Thrombosis

Gene Information Card

Symbol F11
Full Name coagulation factor XI
Gene Type protein-coding
Chromosomal Location 4q35.2
NCBI Gene ID 2160 ncbi.nlm.nih.gov/gene/2160
Ensembl ID ENSG00000088926
UniProt ID P03951
OMIM ID 264900
HGNC ID 3529
Aliases FXI, PTA, factor XI, plasma thromboplastin antecedent

Description

The F11 gene encodes coagulation factor XI (FXI), a serine protease zymogen that circulates in plasma and is activated to FXIa by factor XIIa (FXIIa), thrombin, or autoactivation. FXIa activates factor IX, initiating the intrinsic pathway of blood coagulation. Deficiency of FXI causes hemophilia C, an autosomal bleeding disorder prevalent in Ashkenazi Jews. Gain-of-function variants are associated with increased thrombotic risk.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hemophilia C (Factor XI Deficiency) Loss-of-function mutations in F11 reduce FXI activity, impairing clot formation and causing bleeding tendency. OMIM #264900
Thrombosis (Venous Thromboembolism) Gain-of-function variants (e.g., p.Glu117Lys) increase FXI activity, elevating thrombin generation and thrombotic risk. ClinVar, PMID: 15956284
Myocardial Infarction Elevated FXI levels are associated with increased risk of coronary artery thrombosis. ClinVar, PMID: 16990514

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Plasma N/A Secreted
Bone Marrow 0.3 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 (hepatocellular carcinoma) 10.2 Primary site of synthesis
HUVEC (endothelial) 0.1 Minimal expression
K562 (leukemia) 0.0 No expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.403G>A (p.Glu135Lys) Missense 1-2% in Ashkenazi Jews Loss-of-function; causes hemophilia C
c.124C>T (p.Gln42*) Nonsense <0.1% Loss-of-function; premature truncation
c.1694G>A (p.Glu565Lys) Missense Rare Gain-of-function; increased thrombotic risk
Mutation functional classification

Loss of Function (LOF)

Most F11 mutations are loss-of-function, leading to reduced FXI activity and hemophilia C. Common in Ashkenazi Jewish populations.

Gain of Function (GOF)

Rare missense variants (e.g., p.Glu565Lys) enhance FXI activation or stability, increasing thrombotic risk.

Dominant Negative (DN)

Not well documented; F11 deficiency is typically autosomal recessive.

Pathways

• Intrinsic pathway of coagulation (Reactome: R-HSA-140837)
• Formation of fibrin clot (Reactome: R-HSA-140877)
• Common pathway of coagulation (KEGG: hsa04610)

Protein Summary

Coagulation factor XI (FXI) is a 607-amino-acid glycoprotein synthesized primarily in the liver and secreted into plasma as a homodimer. Each subunit contains four apple domains (AP1-AP4) and a C-terminal trypsin-like serine protease domain. FXI is activated by FXIIa, thrombin, or autoactivation, and in turn activates factor IX. Deficiency causes hemophilia C, while elevated levels or gain-of-function variants predispose to thrombosis.

Related Products

Product name Cat.No. Species Gene ID
F11r Knockout MB49 Cell Line EDJ-KQ54 Mouse 16456 Details Get a Quote
F11 Knockout HEK293 Cell Line EDJ-KQ3628 Human 2160 Details Get a Quote
F11R Knockout HEK293 Cell Line EDJ-KQ10831 Human 50848 Details Get a Quote
F11R Knockout A-549 Cell Line EDJ-KQ38480 Human 50848 Details Get a Quote
F11R Knockout HCT 116 Cell Line EDJ-KQ38481 Human 50848 Details Get a Quote
F11R Knockout HeLa Cell Line EDJ-KQ38482 Human 50848 Details Get a Quote
F11 Knockout HeLa Cell Line EDJ-KQ53190 Human 2160 Details Get a Quote
F11 Knockout A-549 Cell Line EDJ-KQ61669 Human 2160 Details Get a Quote
F11 Knockout HCT 116 Cell Line EDJ-KQ70152 Human 2160 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: